Shenzhen Hepalink Pharmaceutical Group Co Ltd 2023 Sustainability Report
Company: Shenzhen Hepalink Pharmaceutical Group Co Ltd
Sector: Manufacturing
Country: China
Year: 2023
Type: Sustainability Report
Pages: 63
The report describes Board-level responsibility for ESG strategy, reporting and risk oversight. For 2023, the Group reported 55,874.2 tonnes of carbon dioxide equivalent in total Scope 1 and Scope 2 emissions and reported no work-related fatalities. Community initiatives included rural revitalization assistance, cooperation with Guangdong Pharmaceutical University, and support for a biopharmaceutical entrepreneurship competition.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.